ITI Pharma and Healthcare Fund Regular vs HDFC Pharma and Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹1568 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 08 Nov 2021 | 04 Oct 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Dhruv Muchhal |
ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Month | 1.43% | 0.63% |
6 Month | -5.27% | 0.42% |
1 Year | 16.5% | 27.75% |
3 Year | 18.68% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
6 Month | -1.29% | 1.3% |
1 Year | 1.9% | 13% |
3 Year | 22.79% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Year | 22.47% | 51.48% |
3 Year | 18.57% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Standard Deviation | 15.667% | - |
Sharp | 0.739% | - |
Beta | 0.959% | - |
Alpha | -1.413% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Name | Rohan Korde | Dhruv Muchhal |
Total AUM | ₹4626 Cr | ₹520687 Cr |
Funds Managed | 10 | 40 |
ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 7.57 | 4.17 |
Mid Cap | 31.22 | 25.93 |
Small Cap | 32.03 | 34.62 |
Large Cap | 29.19 | 35.28 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 8.42 | 2.47 |
Healthcare | 88.76 | 95.49 |
Basic Materials | 2.08 | 2.04 |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
Kotak Debt Hybrid - Growth
3Y Returns10.62%
SUNDARAM CONSERVATIVE HYBRID FUND Regular Plan - Growth
3Y Returns8.11%
Mirae Asset Dynamic Bond Fund-Regular Plan Growth
3Y Returns6%
UTI Dynamic Bond Fund - Regular Plan - Growth Option
3Y Returns9.81%
LIC MF GILT FUND-Growth
3Y Returns7.25%
LIC MF Government Securities Fund-Regular Plan-Growth
3Y Returns7.25%
LIC MF Gold ETF Fund of Fund -Regular Plan-Growth
3Y Returns20.89%
Edelweiss Gold and Silver ETF FOF - Regular Plan - Growth
3Y Returns0%